EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Clinical heterogeneity and immunotherapy outcomes in anti-GAD65 antibody-associated autoimmune encephalitis: a retrospective study

Yihui Qiu iD, Zhiheng Huang, Tengyun Ma, Lihuan Lan, Guixian Ma, Kun Nie, Yuhu Zhang iD, Lijuan Wang, Jiehao Zhao

Therapeutic Advances in Neurological Disorders · 2026-06 · 19

DOI: 10.1177/17562864261456519 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Therapeutic Advances in Neurological Disorders, online erschienen am 09.06.2026. Verfasst von Yihui Qiu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern M…. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China, Guangdong Provincial Science and Technology Planning Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti-glutamic acid decarboxylase 65 (GAD65) antibody-associated autoimmune encephalitis (AE) is characterized by diverse neurological manifestations and systemic autoimmune comorbidities, posing diagnostic and therapeutic challenges. This study aimed to investigate the clinical heterogeneity, immunological characteristics, neuropathological features, and therapeutic outcomes in patients with anti-GAD65 AE. A retrospective study was performed in six patients with anti-GAD65 AE diagnosed at Guangdong Provincial People’s Hospital. Collected data included demographic, clinical manifestations, cerebrospinal fluid (CSF) profiles, neuroimaging findings, antibody titers, immunotherapy regimens, and histopathology. Initial presentations included epilepsy (50%), hyperthyroidism (33%), and stiff-person syndrome (17%). Concurrent autoimmune diseases (type 1 diabetes, autoimmune thyroiditis, and polyendocrine syndrome) were present in half of the patients. All patients exhibited elevated anti-GAD65 antibody titers in serum and CSF. CSF analysis revealed lymphocytic pleocytosis in one patient and oligoclonal bands in four tested cases. Acute immunotherapy involving corticosteroids and intravenous immunoglobulin achieved seizure control in 83%. Maintenance therapy with mycophenolate mofetil or biologics (e.g., ofatumumab, telitacicept) elicited heterogeneous serological responses, including antibody titer rebound despite clinical stability. Notably, Case 6 represented the first reported case worldwide of AE with triple positivity (anti-GAD65, anti-GABA A Rα1, and anti-GQ1b IgG antibodies), presenting with rapidly progressive cognitive impairment, extensive parenchymal lesions, and extremely high anti-GAD65 titers, yet exhibited significant improvement post-immunotherapy. Histopathology revealed CD3⁺/CD8⁺ T-cell infiltrates in perivascular, meningeal, and parenchymal regions, accompanied by aggregates of CD20⁺ B cells, CD38⁺ plasma cells, GrB⁺ non-T cells (e.g., NK cells), and activated CD68⁺ macrophages/microglia. Anti-GAD65 AE exhibits marked clinical and immunological heterogeneity, involving both humoral and T-cell-mediated pathogenic mechanisms. Coexisting antibodies may exacerbate neuronal injury through mechanisms such as antigen unmasking and antibody-dependent cellular cytotoxicity. Persistent antibody elevation and subclinical immune activity underscore the necessity of integrating multimodal biomarkers and developing personalized treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

anti-GAD65 antibodiesautoimmune encephalitisclinical heterogeneityimmunotherapy

Autor:innen und Institutionen

  • Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong Province, PR China.
  • Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, No. 106, Zhongshan 2nd Road, Guangzhou, Guangdong P…

ORCID-Profile: Yihui Qiu, Yuhu Zhang

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Natural Science Foundation of China
  • Guangdong Provincial Science and Technology Planning Project
  • Science and Technology Planning Project of Guangzhou

Zitieren

APA

Qiu, Y., Huang, Z., Ma, T., Lan, L., Ma, G., Nie, K., Zhang, Y., Wang, L., & Zhao, J. (2026). Clinical heterogeneity and immunotherapy outcomes in anti-GAD65 antibody-associated autoimmune encephalitis: a retrospective study. Therapeutic Advances in Neurological Disorders, 19. https://doi.org/10.1177/17562864261456519

Vancouver

Qiu Y, Huang Z, Ma T, Lan L, Ma G, Nie K, et al. Clinical heterogeneity and immunotherapy outcomes in anti-GAD65 antibody-associated autoimmune encephalitis: a retrospective study. Therapeutic Advances in Neurological Disorders. 2026;19. doi:10.1177/17562864261456519

BibTeX
@article{Qiu2026,
  author = {Qiu, Yihui and Huang, Zhiheng and Ma, Tengyun and Lan, Lihuan and Ma, Guixian and Nie, Kun and Zhang, Yuhu and Wang, Lijuan and Zhao, Jiehao},
  title = {Clinical heterogeneity and immunotherapy outcomes in anti-GAD65 antibody-associated autoimmune encephalitis: a retrospective study},
  journal = {Therapeutic Advances in Neurological Disorders},
  year = {2026},
  volume = {19},
  doi = {10.1177/17562864261456519}
}
Kostenlos starten →